Hisun received a notice from the European Medical Agency (EMA) with respect to its approval for the drug, Tacrolimus Capsules, which Hisun jointly develops with CINFA of Spain. It is the only Tacrolimus generic drug approved for the European market. The product's launch will have a positive impact on the sale of the company's drug in the European market.
Related News
Photos
More>>
trade
- Neusoft Listed in The 2007 Global Services 100
- Dr.Liu Jiren Awarded Asia Innovator of the Year at the 6th CNBC Asia Business
- Neusoft CEO Attended the 2010 Summer Davos and Highlighted the New Challenges
- Neusoft CEO Dr. Liu Jiren Named Country Winner of Ernst and Young Entrepreneur
- Kaisa Group received 2010 Listed Real Estate Company of the Highest Investment
market
- Kaisa Group announces interim results for 2010
- Kaisa Group among TOP10 brands of South China real estate companies 6 years in a
- Kaisa Group earned PRC best employer title for 2010
- Campus recruitment for 2011 graduates started with Shenzhen University
- Kaisa Group named among Most Valuable PRC Listed Blue-chip Real Estate Companies
finance
- Kaisa Group ranks 5th among TOP 10 China-Affiliated HK-Listed Companies of
- Insigma being awarded the Grand Prize for Y2009 International Service Outsourcin
- Insigma Continues to Hold 2nd Place in China s Software Outsourcing Industry in
- Insigma presented at Gartner Outsourcing Summit
- CWHK University alliance key to Insigma s success